MedTrace Logo

WP02 Continued Access Study

NCT04862156 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2025-04-15

Study results available
· View outcomes & findings →

Summary

The single-arm continued access phase will be used to collect additional effectiveness and safety data to support the objectives and outcomes of the original IDE pivotal study.

Conditions

  • Liver Transplantation

Interventions

DEVICE

Normothermic Machine Perfusion (NMP)

Storage and transportation of the donated liver using the OrganOx metra device.

Sponsors & Collaborators

  • North American Science Associates Ltd.

    collaborator NETWORK

  • OrganOx Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-10
Primary Completion
2022-07-31
Completion
2023-07-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04862156 on ClinicalTrials.gov